Pinned Tweet
🔥 From BioData to Real-World Assets (#RWA)
Get ready to witness The Infrastructure Blueprint of Matrix AI Network! 🚀
docs.matrix.io/hong-kong-sta…
✅ Chapter 1: Why Biodata Becomes RWA Capital Now is LIVE!
Stay Tuned...
Science has put a name to something Matrix has been working on.
In The Scramble for Your Brain Data, Jonathan Moens examines the growing race to collect EEG data and train AI models of the brain.
The article names MATRIX and NeuraMATRIX, and quotes Eric Choy on the proposed marketplace for sleep data.
This is no longer a distant possibility. The real question is who gets to shape this emerging economy.
#MatrixAINetwork #Neurotechnology
Your brainwaves might be helping train AI.
And you probably didn't buy your EEG device thinking you'd become part of someone's AI training dataset.
A recent investigation reported that around 50,000 hours of EEG recordings from Muse users had been used to train an AI model.
The issue? The company's earlier privacy policy had not explicitly disclosed that brain recordings could be used to train foundation models. The company later updated its policy and said identifying information was removed.
We're moving into an era where human biology is not just something we measure. It's something AI can learn from.
So here's a question worth asking:
When your body generates valuable data, who gets to decide what happens to it?
#AI #MatrixAINetwork
For readers who want to verify the reporting:
1. Original investigation — Science:
science.org/content/article/…
2. Additional reporting — Tom's Hardware, November 9, 2026:
tomshardware.com/peripherals…
The investigation was conducted by Science with the Pulitzer Center's AI Accountability Network.
In this October AMA, CEO Owen Tao addresses community questions covering:
Exchange challenges: The impact of delistings and the wider exchange landscape.
Mainnet migration: Technical progress, exchange coordination and the possibility of a more gradual transition.
Liquidity and funding: The current challenges and efforts to explore external partnerships and investment.
RWA standards: The status of Matrix's involvement in the CMCA standards work.
Mainnet readiness: Five areas covering security, asset migration, nodes, ecosystem tooling and testnet stability.
BioData quality: Source verification, algorithmic assessment and researcher feedback.
Data security and privacy: Distributed storage, usage rights, privacy-conscious processing and different regulatory environments.
Ecosystem adoption: Institutional data partnerships and user-generated BioData.
This is not a conversation pretending that everything is easy.
Some challenges remain. Some work is progressing. Some ambitions still need to be demonstrated.
But the work continues, and the community deserves to hear the discussion directly.
Watch the full October AMA and join the conversation.
The market has been frightening enough lately. So, for October's AMA, we decided to make Halloween official. 🎃
Behind the costumes, though, were some very real questions.
Exchange delistings. Market conditions. Liquidity and funding. Mainnet migration. BioData quality, security and privacy.
We won't pretend everything is easy, or that every challenge has been resolved.
But difficult times are also when a team needs to keep thinking, building and finding a way forward.
This October AMA is a conversation about where Matrix stands, what we're working through, and what comes next.
Let's bring some energy back to the community. What would you most like to see Matrix deliver next?
#MatrixAINetwork #BioData
A BioData RWA ecosystem needs actual data and actual users.
In the October AMA, the team discussed two routes:
Working with institutions that may contribute existing datasets, and opening the network for individuals to upload their own data.
The initial ambition discussed was to reach hundreds of thousands of user-level records.
That is a target, not an achievement. But it raises the right question:
What would make institutions and individuals willing to contribute meaningful BioData?
#MatrixAINetwork #RWA
The market has been frightening enough lately. So, for October's AMA, we decided to make Halloween official. 🎃
Behind the costumes, though, were some very real questions.
Exchange delistings. Market conditions. Liquidity and funding. Mainnet migration. BioData quality, security and privacy.
We won't pretend everything is easy, or that every challenge has been resolved.
But difficult times are also when a team needs to keep thinking, building and finding a way forward.
This October AMA is a conversation about where Matrix stands, what we're working through, and what comes next.
Let's bring some energy back to the community. What would you most like to see Matrix deliver next?
#MatrixAINetwork #BioData
Human BioData is not ordinary data.
In the October AMA, Owen discussed separating data ownership rights from usage rights, distributed storage, removing private information and processing data differently depending on regulatory requirements.
One particularly interesting direction: in stricter environments, processing may happen on the user's device, with only selected characteristic values or results retrieved.
The original data does not always need to travel for its value to be useful.
How should the industry balance data utility with personal privacy?
#MatrixAINetwork #DataPrivacy
The market has been frightening enough lately. So, for October's AMA, we decided to make Halloween official. 🎃
Behind the costumes, though, were some very real questions.
Exchange delistings. Market conditions. Liquidity and funding. Mainnet migration. BioData quality, security and privacy.
We won't pretend everything is easy, or that every challenge has been resolved.
But difficult times are also when a team needs to keep thinking, building and finding a way forward.
This October AMA is a conversation about where Matrix stands, what we're working through, and what comes next.
Let's bring some energy back to the community. What would you most like to see Matrix deliver next?
#MatrixAINetwork #BioData
More data does not automatically mean better data.
In the October AMA, Matrix described three layers for assessing BioData quality:
• Identifying where the data comes from, including verified hardware sources.
• Using algorithms to detect inconsistencies and abnormal patterns.
• Allowing researchers and users to evaluate the data's usefulness.
Why does this matter?
Because BioData intended for real-world use needs more than volume. It needs credibility.
What would make you trust a BioData record?
#MatrixAINetwork #BioData
🤖 Made with AI
The market has been frightening enough lately. So, for October's AMA, we decided to make Halloween official. 🎃
Behind the costumes, though, were some very real questions.
Exchange delistings. Market conditions. Liquidity and funding. Mainnet migration. BioData quality, security and privacy.
We won't pretend everything is easy, or that every challenge has been resolved.
But difficult times are also when a team needs to keep thinking, building and finding a way forward.
This October AMA is a conversation about where Matrix stands, what we're working through, and what comes next.
Let's bring some energy back to the community. What would you most like to see Matrix deliver next?
#MatrixAINetwork #BioData
A new mainnet needs more than working code.
In the October AMA, the team outlined five areas of preparation:
Security and code integrity
Ledger and asset-swap logistics
Validator and node infrastructure
Ecosystem tools and integrations
Testnet stability and benchmarks
The testnet had already been running for almost three months at the time of the AMA.
Building infrastructure means preparing for what can go wrong, not just demonstrating what can work.
Which of these five areas deserves the most attention?
#MatrixAINetwork #EVM
One of the hardest questions in a difficult market is also one of the most important:
How does a project keep moving without relying on selling tokens at depressed market prices?
In the October AMA, the discussion addressed this concern and mentioned efforts to find external partners, including potential investors.
There is a difference between seeking funding and securing it. We should be clear about that.
What would you want to know when a project discusses its financial sustainability?
#MatrixAINetwork
The market has been frightening enough lately. So, for October's AMA, we decided to make Halloween official. 🎃
Behind the costumes, though, were some very real questions.
Exchange delistings. Market conditions. Liquidity and funding. Mainnet migration. BioData quality, security and privacy.
We won't pretend everything is easy, or that every challenge has been resolved.
But difficult times are also when a team needs to keep thinking, building and finding a way forward.
This October AMA is a conversation about where Matrix stands, what we're working through, and what comes next.
Let's bring some energy back to the community. What would you most like to see Matrix deliver next?
#MatrixAINetwork #BioData
Why is mainnet migration taking time?
Because the work doesn't end when the code is ready.
In the October AMA, the team said most technical migration work had been completed, while exchange coordination remained a major part of the process.
The migration approach may also evolve, potentially allowing two main chains to communicate during the transition rather than relying on a single one-off switch.
No November completion date was confirmed.
Would you prefer a rushed migration or a carefully managed transition?
#MatrixAINetwork #Blockchain
The market has been frightening enough lately. So, for October's AMA, we decided to make Halloween official. 🎃
Behind the costumes, though, were some very real questions.
Exchange delistings. Market conditions. Liquidity and funding. Mainnet migration. BioData quality, security and privacy.
We won't pretend everything is easy, or that every challenge has been resolved.
But difficult times are also when a team needs to keep thinking, building and finding a way forward.
This October AMA is a conversation about where Matrix stands, what we're working through, and what comes next.
Let's bring some energy back to the community. What would you most like to see Matrix deliver next?
#MatrixAINetwork #BioData
Let's address the uncomfortable subject.
The October AMA included a direct question about Matrix following its delisting from KuCoin and MEXC.
The conversation acknowledged the concern and discussed the wider exchange landscape, including other exchange channels and the DEX direction.
A delisting is serious. It affects confidence, access and liquidity. Pretending otherwise helps nobody.
But should the future of a blockchain project be judged by its exchange listings alone?
#MatrixAINetwork #Crypto
The market has been frightening enough lately. So, for October's AMA, we decided to make Halloween official. 🎃
Behind the costumes, though, were some very real questions.
Exchange delistings. Market conditions. Liquidity and funding. Mainnet migration. BioData quality, security and privacy.
We won't pretend everything is easy, or that every challenge has been resolved.
But difficult times are also when a team needs to keep thinking, building and finding a way forward.
This October AMA is a conversation about where Matrix stands, what we're working through, and what comes next.
Let's bring some energy back to the community. What would you most like to see Matrix deliver next?
#MatrixAINetwork #BioData
A little Halloween humour from the October AMA.
Owen was asked how it felt wearing the mask.
His answer? A bit suffocating. 😄
Fair enough. Some things are uncomfortable, even when they look good.
But the real discomfort of this month wasn't the costume. It was the difficult market and the challenges Matrix had to address.
Sometimes a little humour helps us face serious things. What helps you keep perspective during a difficult period?
#MatrixAINetwork #Halloween
The market has been frightening enough lately. So, for October's AMA, we decided to make Halloween official. 🎃
Behind the costumes, though, were some very real questions.
Exchange delistings. Market conditions. Liquidity and funding. Mainnet migration. BioData quality, security and privacy.
We won't pretend everything is easy, or that every challenge has been resolved.
But difficult times are also when a team needs to keep thinking, building and finding a way forward.
This October AMA is a conversation about where Matrix stands, what we're working through, and what comes next.
Let's bring some energy back to the community. What would you most like to see Matrix deliver next?
#MatrixAINetwork #BioData
The market has been frightening enough lately. So, for October's AMA, we decided to make Halloween official. 🎃
Behind the costumes, though, were some very real questions.
Exchange delistings. Market conditions. Liquidity and funding. Mainnet migration. BioData quality, security and privacy.
We won't pretend everything is easy, or that every challenge has been resolved.
But difficult times are also when a team needs to keep thinking, building and finding a way forward.
This October AMA is a conversation about where Matrix stands, what we're working through, and what comes next.
Let's bring some energy back to the community. What would you most like to see Matrix deliver next?
#MatrixAINetwork #BioData
The AI trade is being asked a brutal question: where is the return on all that spending?
There’s another question the industry hasn’t answered nearly as well:
Who can prove the data going into these models is what they claim to be?
A bigger model can amplify good data. It can also amplify bad assumptions.
Which is the more underrated AI bottleneck: compute or evidence?
#MatrixAINetwork #AI
I won't pretend nine years never made me doubt this.
There were stretches where the price fell, the market looked elsewhere, and the quiet question sat there: what if I'm just wrong? Any honest founder has felt it.
What kept me in wasn't blind faith. It was going back to the actual problem, who owns the data your body makes, and finding it still unsolved, still mattering more each year. The doubt never won because the problem never went away.
Here’s a design decision I’m proud of, in plain terms.
We built the new Matrix chain so that every time someone uploads their biodata, a small amount of MAN is destroyed. Permanently. Written into the protocol, not a policy anyone can reverse.
Most tokens quietly print more of themselves. We built one that gets scarcer the more it’s actually used. I wanted the token’s health tied to real usage, not to my promises. Promises are cheap, and I’ve watched too many of them break.
I think a lot about the people who held through nine years of this.
Not the ones chasing the next thing. The ones who read the actual thesis, understood what we were building, and decided it was worth waiting for. Some of them I've never met. Some have been in our channels longer than some of my employees.
Whatever Matrix becomes, it exists because they didn't leave. I don't forget that.
Nineteen billion dollars got liquidated across crypto earlier this month. People asked if I was worried.
I’ve held MAN since 2017. I’ve watched this token lose more value, more times, than most projects ever live to see. I didn’t sell then and I didn’t flinch now.
Volatility isn’t the risk. Building something real that never ships is the risk. One of those I can control. So that’s where I put my attention.
Sunday evening has a special talent.
It can turn a perfectly good weekend into a countdown to Monday. 😂
Maybe the real flex isn't squeezing more productivity out of every hour. Maybe it's having enough energy left to enjoy the life you're working so hard to build.
Sleep well. Go outside. Call someone you miss.
What's one thing you're leaving for next week — without feeling guilty about it?
#MatrixAINetwork #Weekend




















